This indicates that tPOA is more effective than cPOA at ameliorating hypercholesterolemia and that this amelioration is likely achieved by regulating cholesterol metabolism via cholesterol synthesis reduction and absorption and by increasing cholesterol excretion, LXRα as their possible target. This evidence concerns the gene NR1H3 and Hypercholesterolemia.